134 related articles for article (PubMed ID: 30877410)
1. 1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia.
Daniele G; L'Abbate A; Turchiano A; Palumbo O; Carella M; Lo Cunsolo C; Iuzzolino P; Lonoce A; Hernández-Sánchez M; Minoia C; Leone P; Hernandez-Rivas JM; Storlazzi CT
Clin Exp Med; 2019 May; 19(2):261-267. PubMed ID: 30877410
[TBL] [Abstract][Full Text] [Related]
2. A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions.
Tolomeo D; Agostini A; Solimando AG; Cunsolo CL; Cimarosto L; Palumbo O; Palumbo P; Carella M; Hernández-Sánchez M; Hernández-Rivas JM; Storlazzi CT
Cancer Genet; 2023 Apr; 272-273():16-22. PubMed ID: 36641997
[TBL] [Abstract][Full Text] [Related]
3. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
[TBL] [Abstract][Full Text] [Related]
4. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
[TBL] [Abstract][Full Text] [Related]
5. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia.
Quijada-Álamo M; Hernández-Sánchez M; Robledo C; Hernández-Sánchez JM; Benito R; Montaño A; Rodríguez-Vicente AE; Quwaider D; Martín AÁ; García-Álvarez M; Vidal-Manceñido MJ; Ferrer-Garrido G; Delgado-Beltrán MP; Galende J; Rodríguez JN; Martín-Núñez G; Alonso JM; García de Coca A; Queizán JA; Sierra M; Aguilar C; Kohlmann A; Hernández JÁ; González M; Hernández-Rivas JM
J Hematol Oncol; 2017 Apr; 10(1):83. PubMed ID: 28399885
[TBL] [Abstract][Full Text] [Related]
8. Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia.
Kazemi T; Asgarian-Omran H; Hojjat-Farsangi M; Shabani M; Memarian A; Sharifian RA; Razavi SM; Jeddi-Tehrani M; Rabbani H; Shokri F
Int J Cancer; 2008 Nov; 123(9):2113-9. PubMed ID: 18704934
[TBL] [Abstract][Full Text] [Related]
9. A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
Hernández JÁ; Hernández-Sánchez M; Rodríguez-Vicente AE; Grossmann V; Collado R; Heras C; Puiggros A; Martín AÁ; Puig N; Benito R; Robledo C; Delgado J; González T; Queizán JA; Galende J; de la Fuente I; Martín-Núñez G; Alonso JM; Abrisqueta P; Luño E; Marugán I; González-Gascón I; Bosch F; Kohlmann A; González M; Espinet B; Hernández-Rivas JM;
PLoS One; 2015; 10(11):e0143073. PubMed ID: 26630574
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
Sutton LA; Ljungström V; Mansouri L; Young E; Cortese D; Navrkalova V; Malcikova J; Muggen AF; Trbusek M; Panagiotidis P; Davi F; Belessi C; Langerak AW; Ghia P; Pospisilova S; Stamatopoulos K; Rosenquist R
Haematologica; 2015 Mar; 100(3):370-6. PubMed ID: 25480502
[TBL] [Abstract][Full Text] [Related]
12. Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.
Kalla C; Nentwich H; Schlotter M; Mertens D; Wildenberger K; Döhner H; Stilgenbauer S; Lichter P
Genes Chromosomes Cancer; 2005 Feb; 42(2):128-43. PubMed ID: 15543602
[TBL] [Abstract][Full Text] [Related]
13. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).
Burlet B; Ramla S; Fournier C; Abrey-Recalde MJ; Sauter C; Chrétien ML; Rossi C; Duffourd Y; Ragot S; Buriller C; Tournier B; Chapusot C; Nadal N; Racine J; Guy J; Bailly F; Martin L; Casasnovas O; Bastie JN; Caillot D; Albuisson J; Broccardo C; Thieblemont C; Delva L; Maynadié M; Aucagne R; Callanan MB
Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608382
[TBL] [Abstract][Full Text] [Related]
16. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments.
Hu B; Patel KP; Chen HC; Wang X; Wang F; Luthra R; Routbort MJ; Kanagal-Shamanna R; Medeiros LJ; Yin CC; Zuo Z; Ok CY; Loghavi S; Tang G; Tambaro FP; Thompson P; Burger J; Jain N; Ferrajoli A; Bose P; Estrov Z; Keating MJ; Wierda WG
Br J Haematol; 2019 Jun; 185(5):852-864. PubMed ID: 30924136
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
Vollbrecht C; Mairinger FD; Koitzsch U; Peifer M; Koenig K; Heukamp LC; Crispatzu G; Wilden L; Kreuzer KA; Hallek M; Odenthal M; Herling CD; Buettner R
PLoS One; 2015; 10(6):e0129544. PubMed ID: 26053404
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.
Shahjahani M; Mohammadiasl J; Noroozi F; Seghatoleslami M; Shahrabi S; Saba F; Saki N
Cell Oncol (Dordr); 2015 Apr; 38(2):93-109. PubMed ID: 25563586
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 level as a biomarker for 13q14 deletion in CLL.
Degheidy HA; Gadalla SM; Farooqui MZ; Abbasi F; Arthur DC; Bauer SR; Wilson WH; Wiestner A; Stetler-Stevenson MA; Marti GE
Cytometry B Clin Cytom; 2013; 84(4):237-47. PubMed ID: 23674504
[TBL] [Abstract][Full Text] [Related]
20. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
